IP Library Patent Application 17795815
Patent Application
App. No. 17/795,815

IMPROVED DETECTION ASSAYS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/795,815
Abstract

The present disclosure provides improved detection (e.g., diagnostic) assays that utilize a Cas protein collateral cleavage activity.

Claims (22)

1 . A detection method comprising steps of:

contacting a CRISPR-Cas complex comprising:

a Cas protein with collateral cleavage activity that is thermostable at temperatures above at least 60-65° C.; and

a guide RNA selected or engineered to be complementary to a target sequence; with

a sample potentially comprising a nucleic acid of the target sequence.

2 . The method of claim 1 , wherein the step of contacting comprises contacting the CRISRP-Cas complex and sample with a reporter susceptible to cleavage by the Cas protein collateral activity.

3 . The method of claim 1 , wherein the step of contacting comprises incubating for a period of time above the temperature.

4 . The method of claim 1 , further comprising a step of amplifying nucleic acid present in the sample.

5 . The method of claim 4 , wherein the step of amplifying utilizes a thermostable nucleic acid polymerase.

6 . The method of claim 4 , wherein the steps of amplifying and contacting are performed in a single vessel.

7 . The method of claim 1 , wherein the Cas protein is a Cas12 protein.

8 . The method of claim 7 , wherein the Cas protein has an amino acid sequence that is at least 80% identical to that of SEQ ID NO: 15.

9 . The method of claim 7 , wherein the Cas protein has an amino acid sequence having at least 80%, sequence identity to any one of SEQ ID Nos. 3-21, 33-47, 51-56, 68-178, and 274-283.

10 . The method of claim 1 , wherein the Cas protein has an amino acid sequence having 80%, sequence identity to any one of SEQ ID Nos. 1-283.

11 . In a method of performing a detection assay utilizing a Cas protein with collateral cleavage activity, the improvement that comprises utilizing a Cas protein with thermostable collateral cleavage activity.

12 . The improvement of claim 11 , wherein the Cas protein is a Cas12 protein.

13 . The improvement of claim 12 , wherein the Cas protein has an amino acid sequence that is at least 80% identical to that of SEQ ID NO: 15.

14 . The improvement of claim 12 , wherein the Cas protein has an amino acid sequence having at least 80%, sequence identity to any one of SEQ ID Nos. 3-21, 33-47, 51-56, 68-178, and 274-283.

15 . The improvement of claim 11 , wherein a method of performing a detection assay is conducted in a single reaction vessel.

16 . The improvement of claim 11 , wherein the thermostable collateral cleavage activity is thermostable above a temperature of about 60° C.

17 . The improvement of claim 11 , wherein the thermostable collateral cleavage activity is thermostable above a temperature of about 65° C.

18 . The improvement of claim 11 , wherein the Cas protein has an amino acid sequence having at least 80% sequence identity to any one of SEQ ID Nos. 1-283.

Assignments (2)
TERMINATION OF IP SECURITY AGREEMENT Recorded Feb 10, 2025
From: NOVALIS LIFESCIENCES INVESTMENTS II, LP
To: SHERLOCK BIOSCIENCES, INC.
Reel/Frame 070171/0448 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2023
From: MANNING, BRENDAN JOHN; RAMESH, PRADEEP
To: SHERLOCK BIOSCIENCES
Reel/Frame 063866/0071 →